Anna M. Laszlo

Dr. Anna M. Laszlo

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 February 2009 in Arthritis Research & Therapy
Verified
Journal Article
Open access
PDF file
BFBalint Farkas
Balint Farkas
FBFerenc Boldizsar
Ferenc Boldizsar
OTOktavia Tarjanyi
Oktavia Tarjanyi
ALAnna M. Laszlo
Anna M. Laszlo
SLSimon M Lin
Simon M Lin
TGTibor T Glant
Tibor T Glant
Introduction: The major histocompatibility complex (H-2d) and non-major histocompatibility complex genetic backgrounds make the BALB/c strain highly susceptible to inflammatory arthritis and spondylitis. Although different BALB/c colonies develop proteoglycan-induced arthritis and proteoglycan-induced spondylitis in response to immunization with human cartilage proteoglycan, they show significant differences in disease penetrance despite being maintained by the same vendor at either the same or a different location. Methods: BALB/c female mice (24 to 26 weeks old after 4 weeks of acclimatization) were immunized with a suboptimal dose of cartilage proteoglycan to explore even minute differences among 11 subcolonies purchased from five different vendors. In vitro-measured T-cell responses, and serum cytokines and (auto)antibodies were correlated with arthritis (and spondylitis) phenotypic scores. cDNA microarrays were also performed using spleen cells of naïve and immunized BALB/cJ and BALB/cByJ mice (both colonies from The Jackson Laboratory, Bar Harbor, ME, USA), which represent the two major BALB/c sublines. Results: The 11 BALB/c colonies could be separated into high (n = 3), average (n = 6), and low (n = 2) responder groups based upon their arthritis scores. While the clinical phenotypes showed significant differences, only a few immune parameters correlated with clinical or histopathological abnormalities, and seemingly none of them affected differences found in altered clinical phenotypes (onset time, severity or incidence of arthritis, or severity and progression of spondylitis). Affymetrix assay (Affymetrix, Santa Clara, CA, USA) explored 77 differentially expressed genes (at a significant level, P < 0.05) between The Jackson Laboratory's BALB/cJ (original) and BALB/cByJ (transferred from the National Institutes of Health, Bethesda, MD, USA). Fourteen of the 77 differentially expressed genes had unknown function; 24 of 77 genes showed over twofold differences, and only 8 genes were induced by immunization, some in both colonies. Conclusions: Using different subcolonies of the BALB/c strain, we can detect significant differences in arthritis phenotypes, single-nucleotide polymorphisms (SNPs), and a large number of differentially expressed genes, even in non-immunized animals. A number of the known genes (and SNPs) are associated with immune responses and/or arthritis in this genetically arthritis-prone murine strain, and a number of genes of as-yet-unknown function may affect or modify clinical phenotypes of arthritis and/or spondylitis.

18 March 2010 in Arthritis Research & Therapy
Verified
Journal Article
Open access
AAAdrienn Angyal
Adrienn Angyal
CEColt Egelston
Colt Egelston
TKTamás Kobezda
Tamás Kobezda
KOKatalin Olasz
Katalin Olasz
ALAnna M. Laszlo
Anna M. Laszlo
KMKatalin Mikecz
Katalin Mikecz
Introduction: Inflammatory joint destruction in rheumatoid arthritis (RA) may be triggered by autoantibodies, the production of which is supported by autoreactive T cells. Studies on RA and animal models of the disease suggest that T cells recruited in the joints can locally initiate or propagate arthritis. Herein, we investigated the role of joint-homing versus lymphoid organ-homing T cells in the development of proteoglycan-induced arthritis (PGIA), an autoimmune model of RA. Methods: To identify T cells migrating to the joints before and during development of autoimmune arthritis, we transferred fluorescence-labeled T cells, along with antigen-presenting cells, from BALB/c mice with PGIA to naïve syngeneic severe combined immunodeficient (SCID) mice. We then monitored the recruitment of donor T cells in the ankle joints and joint-draining lymph nodes of the recipients using in vivo two-photon microscopy and ex vivo detection methods. To limit T-cell access to the joints, we selectively depleted T cells in the blood circulation by treatment with FTY720, an inhibitor of lymphocyte egress from lymphoid organs. Reduction of T cell presence in both lymphoid organs and blood was achieved by injection of donor cells from which T cells were removed prior to transfer. T and B cells were quantitated by flow cytometry, and antigen (PG)-specific responses were assessed by cell proliferation and serum antibody assays. Results: Despite development of adoptively transferred arthritis in the recipient SCID mice, we found very few donor T cells in their joints after cell transfer. Treatment of recipient mice with FTY720 left the T-cell pool in the lymphoid organs intact, but reduced T cells in both peripheral blood and joints. However, FTY720 treatment failed to inhibit PGIA development. In contrast, arthritis was not seen in recipient mice after transfer of T cell-depleted cells from arthritic donors, and serum autoantibodies to PG were not detected in this group of mice. Conclusions: Our results suggest that antigen-specific T cells, which home to lymphoid organs and provide help to B cells for systemic autoantibody production, play a greater role in the development and progression of autoimmune arthritis than the small population of T cells that migrate to the joints.

8 March 2022 in Sustainability
Verified
Journal Article
Open access
PDF file
KVKorinna Varga
Korinna Varga
JFJudit Fehér
Judit Fehér
BTBence Trugly
Bence Trugly
Dóra DrexlerDóra Drexler
Dóra Drexler
FLFlorian Leiber
Florian Leiber
LTLucius Tamm
Lucius Tamm
Although input use in organic agriculture is strictly regulated, and significantly less contentious inputs are applied in organic than in conventional farming systems, copper, mineral oil, external nutrient input, anthelmintics, antibiotics and vitamins are still commonly used among organic farmers in the EU, partly due to the scarce availability of alternative products and the difficulty of implementing preventive strategies. Moreover, besides the direction set by the European Commission’s organic regulation, only a handful of policy instruments exist at national levels to reduce the use of these contentious inputs. The purpose of this paper is to discuss the results of the RELACS EU-funded project about the current use of copper, mineral oils, external nutrient inputs, anthelmintics, antibiotics and vitamins in organic farming in the EU. The paper is based on six internal reports developed in RELACS which relied on international surveys, in-depth interviews, multiple case study methods, database-based calculations, secondary data sources, plus a survey independent from the reports to map existing policy instruments and voluntary initiatives in the EU aiming to reduce the use of the six input categories. As a result, the paper gives a comprehensive overview of the current consumption of the six contentious inputs within the organic sector, highlighting potential alternative strategies in the pipeline, available preventive measures and the willingness of farmers towards adopting these solutions. It also informs about specific policy instruments already in force, as well as about ongoing voluntary initiatives to reduce contentious inputs. Due to the current dependence of organic farming systems on the six categories of contentious inputs, any sudden phase-out or ban on their usage would do more harm than good to the organic sector. Therefore, gradual, data-driven reduction measures are needed, which require significant further investments in targeted research, and in policy support measures, with the active involvement of agricultural stakeholders.

14 March 2024 in Horticulturae
Verified
Journal Article
Open access
PDF file
RGRita Gyuris
Rita Gyuris
ÁSÁrpád Szabó
Árpád Szabó
ALAnna M. Laszlo
Anna M. Laszlo
ÁGÁdám Gutermuth
Ádám Gutermuth
CSCsilla Sörös
Csilla Sörös
Cherry productivity is challenging in Europe due to the presence of the cherry fruit fly (Rhagoletis cerasi). Trunk injection is an alternative method of insecticide delivery that may improve pesticide performance in controlling pests. In our study, four pesticides (abamectin, acetamiprid, flupyradifurone, and cyantraniliprole) were investigated for trunk injection against R. cerasi. Acetamiprid trunk injection in a minimum dose of 0.56 g/tree was suitable for protection against the pest, the efficacy of the control was over 95%, and the pesticide residue concentrations in the fruits were below the maximum permissible limit in each experiment. The trunk injection and foliar spray of the same dose of acetamiprid were equally effective. In the case of the other three active ingredients (abamectin, flupyradifurone, and cyantraniliprole), the trunk injection method did not prove suitable for practical use due to various reasons, which are detailed in the manuscript.

1 February 2018 in Poultry Science
Verified
Journal Article
Open access
PDF file
ALAnna M. Laszlo
Anna M. Laszlo
Márta LadányiMárta Ladányi
Márta Ladányi
KBKrisztina Boda
Krisztina Boda
JCJozsef Csicsman
Jozsef Csicsman
FBFerenc Bari
Ferenc Bari
MRMarianna Radacs
Marianna Radacs
Several studies have examined the potential biological effects of electromagnetic fields (EMF) on birds; however, little attention has been paid to t